Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Juliet Nakamya"'
Autor:
Mauricio Concha, Lizhen Xu, MacKenzie Horn, Tomoyuki Ohara, Juliet Nakamya, Jan Beyer‐Westendorf, Ashkan Shoamanesh, Alexander Cohen, Per Ladenvall, Stuart J. Connolly, Andrew M. Demchuk
Publikováno v:
Stroke: Vascular and Interventional Neurology, Vol 4, Iss 1 (2024)
Background Andexanet alfa, a specific reversal agent for factor Xa inhibitors, resulted in effective hemostasis in 79% of patients with intracranial bleeding in the ANNEXA‐4 (Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of Factor
Externí odkaz:
https://doaj.org/article/9afe5c2bf3dd4bf3923c253ead8387eb
Autor:
Linda S. B. Johnson, Jonas Oldgren, Tyler W. Barrett, Candace D. McNaughton, Jorge A. Wong, William F. McIntyre, Clifford L. Freeman, Laura Murphy, Gunnar Engström, Michael Ezekowitz, Stuart J. Connolly, Lizhen Xu, Juliet Nakamya, David Conen, Shrikant I. Bangdiwala, Salim Yusuf, Jeff S. Healey
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 18 (2021)
Background Heart failure (HF) is a common complication to atrial fibrillation (AF), leading to rehospitalization and death. Early identification of patients with AF at risk for HF might improve outcomes. We aimed to derive a score to predict 1‐year
Externí odkaz:
https://doaj.org/article/332df64e8cb04f0f99a12de753c5bfa9
Autor:
Nicole Lowres, Jake Olivier, Tze-Fan Chao, Shih-Ann Chen, Yi Chen, Axel Diederichsen, David A Fitzmaurice, Juan Jose Gomez-Doblas, Joseph Harbison, Jeff S Healey, F D Richard Hobbs, Femke Kaasenbrood, William Keen, Vivian W Lee, Jes S Lindholt, Gregory Y H Lip, Georges H Mairesse, Jonathan Mant, Julie W Martin, Enrique Martín-Rioboó, David D McManus, Javier Muñiz, Thomas Münzel, Juliet Nakamya, Lis Neubeck, Jessica J Orchard, Luis Ángel Pérula de Torres, Marco Proietti, F Russell Quinn, Andrea K Roalfe, Roopinder K Sandhu, Renate B Schnabel, Breda Smyth, Apurv Soni, Robert Tieleman, Jiguang Wang, Philipp S Wild, Bryan P Yan, Ben Freedman
Publikováno v:
PLoS Medicine, Vol 16, Iss 9, p e1002903 (2019)
BackgroundThe precise age distribution and calculated stroke risk of screen-detected atrial fibrillation (AF) is not known. Therefore, it is not possible to determine the number needed to screen (NNS) to identify one treatable new AF case (NNS-Rx) (i
Externí odkaz:
https://doaj.org/article/930f5530ca2c41ff9cdd4cff1faf354a
Autor:
Mauricio Concha, Lizhen Hu, MacKenzie Horn, Tomoyuki Ohara, Juliet Nakamya, Jan Beyer, Askan Shoamanesh, Alexander T Cohen, Per Ladenvall, Stuart J Connolly, Andrew M Demchuk
Publikováno v:
Stroke. 54
Introduction: Andexanet, a specific reversal agent for FXa inhibitors, showed an effective hemostasis in 82% of patients with major bleeding in the ANNEXA-4 trial. However, little is known about the predictors associated with hematoma expansion in pa
Autor:
John W. Eikelboom, Elena Zotova, Saskia Middeldorp, Andrew M. Demchuk, Pamela B. Conley, Tomoyuki Ohara, John T. Curnutte, Truman J. Milling, Mark Crowther, Stuart J. Connolly, Lizhen Xu, Peter Verhamme, Juliet Nakamya, Patrick Yue, Jose Lopez-Sendon, Joshua N. Goldstein
Publikováno v:
Stroke, 52(6), 2096-2105. Lippincott Williams and Wilkins
Stroke, 52, 6, pp. 2096-2105
Stroke, 52, 2096-2105
Stroke, 52, 6, pp. 2096-2105
Stroke, 52, 2096-2105
Background and Purpose: Andexanet alfa is a recombinant modified human FXa (factor Xa) developed to reverse FXa inhibition from anticoagulants. Hemostatic efficacy and reversal of anti-FXa activity with andexanet were assessed in patients from the AN
Autor:
William F. McIntyre, Salim Yusuf, Jeff S. Healey, Stuart J. Connolly, Michael Ezekowitz, Clifford L. Freeman, Lizhen Xu, David Conen, Juliet Nakamya, Gunnar Engström, Laura Murphy, Candace D. McNaughton, Jonas Oldgren, Tyler W. Barrett, Linda S B Johnson, Shrikant I. Bangdiwala, Jorge A. Wong
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 18 (2021)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 18 (2021)
Background Heart failure (HF) is a common complication to atrial fibrillation (AF), leading to rehospitalization and death. Early identification of patients with AF at risk for HF might improve outcomes. We aimed to derive a score to predict 1‐year
Autor:
Juliet Nakamya, Paul A. Frydrych, Andrea Thornton, F. Russell Quinn, David J. Gladstone, Roopinder K. Sandhu, Valerie Congdon, Ken Ng, Gord Blackhouse, Sam Henein, Richard Birtwhistle, Natasha Burke, Jeff S. Healey, Chinthanie Ramasundarahettige, Jean-Eric Tarride, Lisa Dolovich, Richard Ward, Noah Ivers
Publikováno v:
Canadian Journal of Cardiology. 34:1522-1525
We present an economic evaluation of a recently completed cohort study in which 2054 seniors were screened for atrial fibrillation (AF) in 22 Canadian family practices. Using a Markov model, trial and literature data were used to project long-term ou
Autor:
Richard P, Whitlock, Emilie P, Belley-Cote, Domenico, Paparella, Jeff S, Healey, Katheryn, Brady, Mukul, Sharma, Wilko, Reents, Petr, Budera, Andony J, Baddour, Petr, Fila, P J, Devereaux, Alexander, Bogachev-Prokophiev, Andreas, Boening, Kevin H T, Teoh, Georgios I, Tagarakis, Mark S, Slaughter, Alistair G, Royse, Shay, McGuinness, Marco, Alings, Prakash P, Punjabi, C David, Mazer, Richard J, Folkeringa, Andrea, Colli, Álvaro, Avezum, Juliet, Nakamya, Kumar, Balasubramanian, Jessica, Vincent, Pierre, Voisine, Andre, Lamy, Salim, Yusuf, Stuart J, Connolly, Yasushi, Sakata
BACKGROUND Surgical occlusion of the left atrial appendage has been hypothesized to prevent ischemic stroke in patients with atrial fibrillation, but this has not been proved. The procedure can be performed during cardiac surgery undertaken for other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de2532e463b4bc030fc36eccf3a013ac
http://hdl.handle.net/11568/1137423
http://hdl.handle.net/11568/1137423
Autor:
F. Russell Quinn, Vivian W Y Lee, Philipp S. Wild, David Fitzmaurice, William Keen, Yi Chen, Georges H. Mairesse, Julie W. Martin, Juan José Gómez-Doblas, Jake Olivier, Thomas Münzel, Juliet Nakamya, FD Richard Hobbs, Nicole Lowres, Joseph Harbison, Ben Freedman, Jeff S. Healey, Breda Smyth, Gregory Y.H. Lip, Andrea K Roalfe, Shih Ann Chen, Roopinder K. Sandhu, Luis Ángel Pérula de Torres, Tze Fan Chao, Jonathan Mant, Axel Cosmus Pyndt Diederichsen, Bryan P. Yan, Femke Kaasenbrood, Lis Neubeck, Marco Proietti, Ji-Guang Wang, David D. McManus, Jessica Orchard, Renate B. Schnabel, Enrique Martín-Rioboó, Jes S. Lindholt, Javier Muñiz, Robert G. Tieleman, Apurv Soni
Publikováno v:
RUC. Repositorio da Universidade da Coruña
instname
Lowres, N, Olivier, J, Chao, T F, Chen, S A, Chen, Y, Diederichsen, A, Fitzmaurice, D A, Gomez-Doblas, J J, Harbison, J, Healey, J S, Hobbs, F D R, Kaasenbrood, F, Keen, W, Lee, V W, Lindholt, J S, Lip, G Y H, Mairesse, G H, Mant, J, Martin, J W, Martín-Rioboó, E, McManus, D D, Muñiz, J, Münzel, T, Nakamya, J, Neubeck, L, Orchard, J J, Pérula de Torres, L Á, Proietti, M, Quinn, F R, Roalfe, A K, Sandhu, R K, Schnabel, R B, Smyth, B, Soni, A, Tieleman, R, Wang, J, Wild, P S, Yan, B P & Freedman, B 2019, ' Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening : a multicountry patient-level meta-analysis of 141,220 screened individuals ', PLoS Medicine, vol. 16, no. 9, e1002903 . https://doi.org/10.1371/journal.pmed.1002903
PLoS Medicine
Lowres, N, Olivier, J, Chao, T-F, Chen, S-A, Chen, Y, Diederichsen, A, Fitzmaurice, D A, Gomez-Doblas, J J, Harbison, J, Healey, J S, Hobbs, F D R, Kaasenbrood, F, Keen, W, Lee, V W, Lindholt, J S, Lip, G Y H, Mairesse, G H, Mant, J, Martin, J W, Martín-Rioboó, E, McManus, D D, Muñiz, J, Münzel, T, Nakamya, J, Neubeck, L, Orchard, J J, Pérula de Torres, L Á, Proietti, M, Quinn, F R, Roalfe, A K, Sandhu, R K, Schnabel, R B, Smyth, B, Soni, A, Tieleman, R, Wang, J, Wild, P S, Yan, B P & Freedman, B 2019, ' Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening : a multicountry patient-level meta-analysis of 141,220 screened individuals ', PLOS Medicine, vol. 16, no. 9, e1002903, pp. 1-19 . https://doi.org/10.1371/journal.pmed.1002903
PLoS Medicine, Vol 16, Iss 9, p e1002903 (2019)
instname
Lowres, N, Olivier, J, Chao, T F, Chen, S A, Chen, Y, Diederichsen, A, Fitzmaurice, D A, Gomez-Doblas, J J, Harbison, J, Healey, J S, Hobbs, F D R, Kaasenbrood, F, Keen, W, Lee, V W, Lindholt, J S, Lip, G Y H, Mairesse, G H, Mant, J, Martin, J W, Martín-Rioboó, E, McManus, D D, Muñiz, J, Münzel, T, Nakamya, J, Neubeck, L, Orchard, J J, Pérula de Torres, L Á, Proietti, M, Quinn, F R, Roalfe, A K, Sandhu, R K, Schnabel, R B, Smyth, B, Soni, A, Tieleman, R, Wang, J, Wild, P S, Yan, B P & Freedman, B 2019, ' Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening : a multicountry patient-level meta-analysis of 141,220 screened individuals ', PLoS Medicine, vol. 16, no. 9, e1002903 . https://doi.org/10.1371/journal.pmed.1002903
PLoS Medicine
Lowres, N, Olivier, J, Chao, T-F, Chen, S-A, Chen, Y, Diederichsen, A, Fitzmaurice, D A, Gomez-Doblas, J J, Harbison, J, Healey, J S, Hobbs, F D R, Kaasenbrood, F, Keen, W, Lee, V W, Lindholt, J S, Lip, G Y H, Mairesse, G H, Mant, J, Martin, J W, Martín-Rioboó, E, McManus, D D, Muñiz, J, Münzel, T, Nakamya, J, Neubeck, L, Orchard, J J, Pérula de Torres, L Á, Proietti, M, Quinn, F R, Roalfe, A K, Sandhu, R K, Schnabel, R B, Smyth, B, Soni, A, Tieleman, R, Wang, J, Wild, P S, Yan, B P & Freedman, B 2019, ' Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening : a multicountry patient-level meta-analysis of 141,220 screened individuals ', PLOS Medicine, vol. 16, no. 9, e1002903, pp. 1-19 . https://doi.org/10.1371/journal.pmed.1002903
PLoS Medicine, Vol 16, Iss 9, p e1002903 (2019)
Background The precise age distribution and calculated stroke risk of screen-detected atrial fibrillation (AF) is not known. Therefore, it is not possible to determine the number needed to screen (NNS) to identify one treatable new AF case (NNS-Rx) (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39465de71c1b89c8ccdabc0240bd94f4
https://www.repository.cam.ac.uk/handle/1810/296426
https://www.repository.cam.ac.uk/handle/1810/296426
Autor:
Albertino Damasceno, Juliet Nakamya, Salim Yusuf, Jonas Oldgren, Jeff S. Healey, Paul A. Reilly, Jia Wang, Petr Jansky, Stuart J. Connolly, Wael Almahmeed, Akinyemi Aje, Andrew Moriarty, Alex Grinvalds, Alvaro Avezum, Jun Zhu, Prem Pais, Alben Sigamani, Michael D. Ezekowitz, Patrick J. Commerford, Lars Wallentin
Publikováno v:
The Lancet. 388:1161-1169
Summary Background Atrial fibrillation is an important cause of morbidity and mortality worldwide, but scant data are available for long-term outcomes in individuals outside North America or Europe, especially in primary care settings. Methods We did